Fig. 1From: The economic cost of implementing antigen-based rapid diagnostic tests for COVID-19 screening in high-risk transmission settings: evidence from GermanyCost structure per Ag-RDT implemented at UKHD and Charité (non-dedicated mode)Back to article page